NASDAQ Companies

 Investigational Review Board (IRB) approval has been granted for 60 Degrees Pharma’s double-blind, placebo-controlled study to investigate tafenoquine for treatment […]

GUANGZHOU, China, Dec. 26, 2023 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading […]

James Bucher, J.D. joins as Chief Legal Officer Wendy Chang promoted to Chief People Officer SOUTH SAN FRANCISCO, Calif., Dec. […]

Tortola, British Virgin Islands, Dec. 26, 2023 (GLOBE NEWSWIRE) — SEALSQ Appoints Vice President of Global Sales December 26, 2023: […]

Transaction Brings RayzeBio’s Differentiated Actinium-Based Radiopharmaceutical Platform, Including Rich Pipeline of Multiple Drug Development Programs to Bristol Myers Squibb’s Leading […]

Charging Robotics received funding from the Israel Innovation Authority for its pilot project to develop and demonstrate its solution for […]

Darren Cahill, ATP Coach Of The Year, Reviews App‘Freemium’ Launch Planned for February 2024 Windsor Mills, MD, Dec. 26, 2023 […]

MONTREAL and CHARLOTTE, N.C., Dec. 26, 2023 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) announced today that the Company received […]

BEIJING, Dec. 26, 2023 (GLOBE NEWSWIRE) — AirNet Technology Inc., formerly known as AirMedia Group Inc. (“AirNet” or the “Company”) […]

PARIS and CAMBRIDGE, Mass., Dec. 26, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), […]